ロード中...

KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer

Tumors driven by mutant KRAS are among the most aggressive and refractory to treatment. Unfortunately, despite the efforts, targeting alterations of this GTPase, either directly or by acting on the downstream signaling cascades, has been, so far, largely unsuccessful. However, recently, novel therap...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Pupo, Emanuela, Avanzato, Daniele, Middonti, Emanuele, Bussolino, Federico, Lanzetti, Letizia
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6730590/
https://ncbi.nlm.nih.gov/pubmed/31544066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00848
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!